pharmaceutical-investing AMAG Pharmaceuticals Announces Topline Results From the PROLONG Trial Evaluating Makena
pharmaceutical-investing AMAG Pharmaceuticals Acquires Orphan Drug Candidate for Treatment of Severe Preeclampsia
pharmaceutical-investing AMAG Pharmaceuticals Submits a New Drug Application to the U.S. Food and Drug Administration
pharmaceutical-investing AMAG Pharmaceuticals Announces FDA Approval of Supplemental New Drug Application for Feraheme
pharmaceutical-investing AMAG and Endoceutics Enter Into an Exclusive U.S. License Agreement for Intrarosa™ (Prasterone)
pharmaceutical-investing AMAG Pharmaceuticals Announces Closing of Exclusive Licensing Agreement for North American Rights to Rekynda™
AMAG Pharmaceuticals Announces Achievement of Key Milestones in Next Generation Development Programs for Makena® and Feraheme®
African Discovery Group announces signing of Definitive Sales and Purchase Agreement for Butembo Copper Asset in the Democratic Republic of Congo; name change to Copper Intelligence, Inc
Saga Metals Acknowledges U.S. Strategic Critical Minerals Reserve "Project Vault" and Highlights Titanium's Strategic Importance to North American Defense Supply Chains
Blackrock Silver to Present at the Precious Metals and Critical Minerals Virtual Investor Conference on February 10th 2026
